Indian Journal of Urology Users online:2902  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1When to Avoid a Restaging Procedure for Non-muscle Invasive Bladder Cancer? Inferences from a Tertiary Care Center
Deepak Prakash Bhirud,Ankur Mittal,Sunil Kumar,Tushar Aditya Narain,Sanjeev Kishore,Shiv Charan Navriya,Satish Kumar Ranjan,Vikas Kumar Panwar
Indian Journal of Surgical Oncology.2022;13(3)604
[DOI]
2Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances
Catarina Lourenço,Vera Constâncio,Rui Henrique,Ângela Carvalho,Carmen Jerónimo
Cancers.2021;13(7)1529
[DOI]
3The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness
Ciro Andolfi,Jeffrey C. Bloodworth,Apostolos Papachristos,Randy F. Sweis
Bladder Cancer.2020;6(3)225
[DOI]
4Spinal Tuberculosis Secondary to Intravesical Bacille Calmette-Guerin Treatment for Bladder Cancer
Celeste G Yergin,Ryan Pafford,John Pirris,Dinesh Rao,Gazanfar Rahmathulla
Cureus.2021;6(3)225
[DOI]
5How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience
Zhen Li,Nienie Qi,Zhimin Gao,Li Ding,Jiawei Zhu,Qingxiang Guo,Junqi Wang,Rumin Wen,Hailong Li
Journal of Clinical Medicine.2022;12(1)169
[DOI]
6Does post-void residual urine volume affect potential recurrence risk for non-muscle invasive bladder cancer?
Mohammad Talal Al-Zubi,Saddam Al Demour,Samer Fathi Al-Rawashdah,Antonio Carbone,Antonio Luigi Pastore,Mohannad Abuhamad,Saleh Abuorouq,Rami Al-Azab,Morad Bani-Hani,Mohammad Al-Qudah,Basel Elayan
Future Science OA.2022;8(9)169
[DOI]
7Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence
Agustina Bessa,Rebecca Martin,Christel Häggström,Deborah Enting,Suzanne Amery,Muhammad Shamim Khan,Fidelma Cahill,Harriet Wylie,Samantha Broadhead,Kathryn Chatterton,Sachin Malde,Rajesh Nair,Ramesh Thurairaja,Pardeep Kumar,Anna Haire,Saran Green,Margaret Northover,Karen Briggs,Mieke Van Hemelrijck
BMC Urology.2020;20(1)169
[DOI]
8Mycobacterium bovis bacille Calmette–Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy
Patrick Gellings,Michelle Galeas-Pena,Lisa A. Morici
Clinical and Experimental Medicine.2022;20(1)169
[DOI]
9Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer
Li Ding,Xiaobin Deng,Wentao Xia,Kun Wang,Yang Zhang,Yan Zhang,Xianfeng Shao,Junqi Wang
Frontiers in Immunology.2022;13(1)169
[DOI]
10BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine
Omodele Ashiru,Gloria Esteso,Eva M. García-Cuesta,Eva Castellano,Celia Samba,Eva Escudero-López,Sheila López-Cobo,Mario Álvarez-Maestro,Ana Linares,Mei M. Ho,Asier Leibar,Luis Martínez-Pińeiro,Mar Valés-Gómez
Cancers.2019;11(7)940
[DOI]
11Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis
Yu Lu,Jing Tao
Frontiers in Endocrinology.2021;12(7)940
[DOI]
12Synthesis and characterization of gold nanoparticles from Abies spectabilis extract and its anticancer activity on bladder cancer T24 cells
Tao Wu,Xi Duan,Chunyan Hu,Changqiang Wu,Xiaobin Chen,Jing Huang,Junbo Liu,Shu Cui
Artificial Cells, Nanomedicine, and Biotechnology.2019;47(1)512
[DOI]
13Bladder cancer diagnosis with a four-miRNA panel in serum
Xinji Li,Wenkang Chen,Rongkang Li,Xuan Chen,Guocheng Huang,Chong Lu,Zhenyu Wen,Xiqi Peng,Kaihao Liu,Chunduo Zhang,Hang Li,Yimin Hu,Zhengping Zhao,Lingzhi Tao,Yongqing Lai
Future Oncology.2022;18(29)3311
[DOI]
14Formulation and characterization of EGCG for the treatment of superficial bladder cancer
Katarzyna Dettlaff,Maciej Stawny,Magdalena Ogrodowczyk,Anna Jelinska,Waldemar Bednarski,Dorota Watróbska-Swietlikowska,Rick W. Keck,Omar A. Khan,Ibrahim H. Mostafa,Jerzy Jankun
International Journal of Molecular Medicine.2017;40(2)329
[DOI]
15Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer
Jorge Daza,Ralph Grauer,Sophie Chen,Etienne Lavallče,Shirin Razdan,Linda Dey,Gunnar Steineck,Lotta Renström-Koskela,Qiang Li,Ahmed A. Hussein,Reza Mehrazin,Nikhil Waingankar,Khurshid Guru,Peter Wiklund,John P. Sfakianos
Urologic Oncology: Seminars and Original Investigations.2023;40(2)329
[DOI]
16A Way Forward for Cancer Chemoprevention: Think Local
Luai Al Rabadi,Raymond Bergan
Cancer Prevention Research.2017;10(1)14
[DOI]
17Active surveillance for nonmuscle invasive bladder cancer
Makito Miyake,Kiyohide Fujimoto,Yoshihiko Hirao
Investigative and Clinical Urology.2016;57(Suppl 1)S4
[DOI]
18Expression of L-Type Amino Acid Transporter 1 is a Predictive Biomarker of Intravesical Recurrence in Patients with Non-Muscle Invasive Bladder Cancer
Harutake Sawazaki,Yuichi Arai,Yuji Ito,Kimiya Sato,Hitoshi Tsuda,Takashi Yamaga,Hiroyuki Sakurai
Research and Reports in Urology.2021;Volume 13(Suppl 1)603
[DOI]
19Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer
Tvrtko Hudolin,Zeljko Kastelan,Ahmad El-Saleh,Mirko Bakula,Marijana Coric,Petar Kes,Davor Tomas,Nikolina Basic-Jukic
Oncology Letters.2019;Volume 13(Suppl 1)603
[DOI]
20Increased Bacillus Calmette-Guérin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non–Muscle-invasive Bladder Cancer in United States Clinical Practice
Kyle A. Richards,Shih-Wen Lin,Ching-Yi Chuo,Christina L. Derleth,Jingbo Yi,Marko Zivkovic,Sarika Ogale,Sandip Prasad,G. Joel Decastro,Gary D. Steinberg
Urology.2020;145(Suppl 1)172
[DOI]
21Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions
Kuan-Wei Shih,Wei-Chieh Chen,Ching-Hsin Chang,Ting-En Tai,Jeng-Cheng Wu,Andy C. Huang,Ming-Che Liu
Aging and disease.2021;12(3)868
[DOI]
22Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer
Hajar El Ahanidi,Meryem El Azzouzi,Chaimae Hafidi Alaoui,Mohammed Tetou,Mounia Bensaid,Imane Chaoui,Laila Benbacer,Ilias Hassan,Mohamed Oukabli,Katarzyna Michaud,Ahmed Ameur,Abderrahmane Al Bouzidi,Mohammed El Mzibri,Camilla Jandus,Mohammed Attaleb
Frontiers in Oncology.2022;11(3)868
[DOI]
23Risk-Based Assessment Of the Impact Of Intravesical Therapy on Recurrence-Free Survival Rate Following Resection of Suspected Low-grade, Non-muscle-invasive Bladder Cancer (NMIBC): A Southwest Oncology Groups (SWOG) S0337 Posthoc Analysis
Nicholas J. Corsi,Edward M. Messing,Akshay Sood,Jacob Keeley,Chandler Bronkema,Nikola Rakic,Marcus Jamil,Deepansh Dalela,Sohrab Arora,Austin J. Piontkowski,Sami E. Majdalany,Mohit Butaney,Ivan Rakic,Pin Li,Mani Menon,Craig G. Rogers,Firas Abdollah
Clinical Genitourinary Cancer.2022;20(6)e498
[DOI]
24Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues
Hugo de Jonge,Luisa Iamele,Maristella Maggi,Greta Pessino,Claudia Scotti
Cancers.2021;13(4)813
[DOI]
25Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer
Li Ding,Xiaobin Deng,Kun Wang,Wentao Xia,Yang Zhang,Yan Zhang,Xianfeng Shao,Junqi Wang
Journal of Inflammation Research.2023;Volume 16(4)283
[DOI]
26Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models
Aleksandar Janev,Taja Železnik Ramuta,Larisa Tratnjek,Žiga Sardoc,Hristina Obradovic,Slavko Mojsilovic,Milena Taskovska,Tomaž Smrkolj,Mateja Erdani Kreft
Frontiers in Bioengineering and Biotechnology.2021;9(4)283
[DOI]
27An insight into the diagnostic and prognostic value of HOX A13 ’s expression in non-muscle invasive bladder cancer
Nouha Setti Boubaker,Aymone Gurtner,Nesrine Trabelsi,Isabella Manni,Ahlem Blel,Ahmed Saadi,Marouene Chakroun,Zeineb Naimi,Selim Zaghbib,Meriam Ksontini,Khedija Meddeb,Soumaya Rammeh,Haroun Ayed,Mohamed Chebil,Giulia Piaggio,Slah Ouerhani
Journal of Clinical Laboratory Analysis.2022;36(9)283
[DOI]
28Radical treatment of muscle-invasive bladder cancer—are options equal?
David Fackrell,Andrea Marshall,Pankaj Mistry,Janet Dunn,Maria De Santis,Daniel Ford,Anjali Zarkar
Journal of Radiation Oncology.2018;7(2)181
[DOI]
29Cancer-Associated Membrane Protein as Targeted Therapy for Bladder Cancer
Adlina Roslan,Nurshahira Sulaiman,Khairul Asri Mohd Ghani,Armania Nurdin
Pharmaceutics.2022;14(10)2218
[DOI]
30Prediction of Bladder Cancer Treatment Side Effects Using an Ontology-Based Reasoning for Enhanced Patient Health Safety
Chamseddine Barki,Hanene Boussi Rahmouni,Salam Labidi
Informatics.2021;8(3)55
[DOI]
31Preoperative systemic immune-inflammation index as a significant prognostic factor after TURBT in patients with non-muscle-invasive bladder cancer: A retrospective study based on propensity score matching analysis
Li Ding,Xiangbu Wang,Xiaobin Deng,Wentao Xia,Kun Wang,Xianlin Yu,Yaotian Huang,Junqi Wang
Cancer Medicine.2022;8(3)55
[DOI]
32The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer
Orsolya Mártha,Daniel Balan,Daniel Porav-Hodade,Emoke Drágus,Mihai Dorin Vartolomei,Calin Bogdan Chibelean,Angela Borda,Ákos Pytel,Olivér Árpád Vida
Revista Romana de Medicina de Laborator.2020;28(1)29
[DOI]
33Non-muscle invasive bladder cancer tissues have increased base excision repair capacity
Berna Somuncu,Selcuk Keskin,Fatma Merve Antmen,Yesim Saglican,Aysegul Ekmekcioglu,Tugce Ertuzun,Mustafa Bilal Tuna,Can Obek,David M. Wilson,Umit Ince,Ali Riza Kural,Meltem Muftuoglu
Scientific Reports.2020;10(1)29
[DOI]
34Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis
Richard Colling,Hayleigh Colling,Lisa Browning,Clare Verrill
BMC Cancer.2021;21(1)29
[DOI]
35Physical activity patterns and associations with health-related quality of life in bladder cancer survivors
Ajay Gopalakrishna,Thomas A. Longo,Joseph J. Fantony,Michael R. Harrison,Brant A. Inman
Urologic Oncology: Seminars and Original Investigations.2017;35(9)540.e1
[DOI]
36Microbiome in Bladder Cancer: A Systematic Review
Yong-Nam Gwon,Jae-Joon Park,Ki-Soo Lee,Kong-Hee Lee,Tae-Hyo Kim,Jae-Heon Kim
Diagnostics.2022;13(1)84
[DOI]
37Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
Mahmoud Ganji,Shohreh Bakhshi,Alireza Shoari,Reza Ahangari Cohan
Journal of Translational Medicine.2023;21(1)84
[DOI]
38Anticancer Effects of Gold Nanoparticles by Inducing Apoptosis in Bladder Cancer 5637 Cells
Sajedeh Daei,Nasrin Ziamajidi,Roghayeh Abbasalipourkabir,Korosh Khanaki,Fatemeh Bahreini
Biological Trace Element Research.2022;200(6)2673
[DOI]
39Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer
Eman N. Khorshid,Mervat M.F. El Deftar,Ghada S. Osman
Egyptian Journal of Pathology.2017;37(2)352
[DOI]
40Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer
Sanchia S. Goonewardene,Raj Persad,Hanif Motiwala,David Albala
Egyptian Journal of Pathology.2020;37(2)123
[DOI]
41The Impact of Physical Activity on Risk and Health-Related Quality of Life in Bladder Cancer
Marina Rodríguez Cintas,Sara Márquez,Javier González-Gallego
Bladder Cancer.2021;7(3)355
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us

Fosfocin